István Wittmann

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Cross Sectional

Oxidative Stress

Top Venues

BMJ open diabetes research & care

Antioxidants (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Gergő A Molnár, Zoltán Vokó, Gábor Sütő, György Rokszin, Dávid Nagy, György Surján, Orsolya Surján, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, Cecília Müller, Miklós Kásler, István Wittmann, Zoltan Kiss
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study). BMJ open diabetes research & care 12 (1) (2024)
Zsolt Abonyi-Tóth, György Rokszin, Gábor Sütő, Ibolya Fábián, Zoltán Kiss, György Jermendy, Péter Kempler, Csaba Lengyel, István Wittmann, Gergő Attila Molnár
Incident Cancer Risk of Patients with Prevalent Type 2 Diabetes Mellitus in Hungary (Part 2). Cancers 16 (13) (2024)
Zsolt Abonyi-Tóth, György Rokszin, Ibolya Fábián, Zoltán Kiss, György Jermendy, Péter Kempler, Csaba Lengyel, István Wittmann, Gergő Attila Molnár, Gábor Sütő
Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1). Cancers 16 (9) (2024)
Zsolt Abonyi-Tóth, György Rokszin, Gábor Sütő, Ibolya Fábián, Zoltán Kiss, György Jermendy, Péter Kempler, Csaba Lengyel, István Wittmann, Gergő Attila Molnár
Incident Cancer Risk of Patients with Prevalent Type 2 Diabetes Mellitus in Hungary (Part 2). Cancers 16 (13) (2024)
Gergő A Molnár, Zoltán Vokó, Gábor Sütő, György Rokszin, Dávid Nagy, György Surján, Orsolya Surján, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, Cecília Müller, Miklós Kásler, István Wittmann, Zoltan Kiss
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study). BMJ open diabetes research & care 12 (1) (2024)
Zsolt Abonyi-Tóth, György Rokszin, Ibolya Fábián, Zoltán Kiss, György Jermendy, Péter Kempler, Csaba Lengyel, István Wittmann, Gergő Attila Molnár, Gábor Sütő
Incident Cancer Risk in Patients with Incident Type 2 Diabetes Mellitus in Hungary (Part 1). Cancers 16 (9) (2024)
Gergő A Molnár, Zoltán Vokó, Gábor Sütő, György Rokszin, Dávid Nagy, György Surján, Orsolya Surján, Péter Nagy, István Kenessey, András Wéber, Mihály Pálosi, Cecília Müller, Miklós Kásler, István Wittmann, Zoltan Kiss
Effectiveness of SARS-CoV-2 primary vaccines and boosters in patients with type 2 diabetes mellitus in Hungary (HUN-VE 4 Study). BMJ open diabetes research & care 12 (1) (2024)
Gábor Bánfai, Peter Laszlo Kanizsai, Csaba Csontos, Szilárd Kun, Ágnes Lakatos, Anikó Lajtai, Vanessza Lelovics, Sándor Szukits, Péter Bogner, Attila Miseta, István Wittmann, Gergő Attila Molnár
Plasma Levels and Renal Handling of Amino Acids Contribute to Determination of Risk of Mortality or Feed of Ventilation in Patients with COVID-19. Metabolites 12 (6) (2022)
István Wittmann
The Common Single Cause of Chronic Multi-Hormonal Resistance in Oxidative Stress. Antioxidants (Basel, Switzerland) 12 (1) (2022)
Judit Mohás-Cseh, Gergő Attila Molnár, Marianna Pap, Boglárka Laczy, Tibor Vas, Melinda Kertész, Krisztina Németh, Csaba Hetényi, Orsolya Csikós, Gábor K Tóth, Attila Reményi, István Wittmann
Incorporation of Oxidized Phenylalanine Derivatives into Insulin Signaling Relevant Proteins May Link Oxidative Stress to Signaling Conditions Underlying Chronic Insulin Resistance. Biomedicines 10 (5) (2022)
István Wittmann
The Common Single Cause of Chronic Multi-Hormonal Resistance in Oxidative Stress. Antioxidants (Basel, Switzerland) 12 (1) (2022)
György Jermendy, Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, Csaba Lengyel, Péter Kempler, István Wittmann
Changing Patterns of Antihyperglycaemic Treatment among Patients with Type 2 Diabetes in Hungary between 2015 and 2020-Nationwide Data from a Register-Based Analysis. Medicina (Kaunas, Lithuania) 58 (10) (2022)
Gábor Sütő, Gergő Attila Molnár, Gyorgy Rokszin, Ibolya Fábián, Zoltan Kiss, Zoltán Szekanecz, Gyula Poór, György Jermendy, Peter Kempler, István Wittmann
Risk of morbidity and mortality in patients with type 2 diabetes treated with sodium-glucose cotransporter-2 inhibitor and/or dipeptidyl peptidase-4 inhibitor: a nationwide study. BMJ open diabetes research & care 9 (1) (2021)
Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, György Jermendy, Péter Kempler, László Barkai, István Wittmann
Young adult patients with type 1 diabetes have a higher risk of mortality than those of similar age with type 2 diabetes: A nationwide analysis in Hungary. Diabetes/metabolism research and reviews 35 (8) (2019)
Zoltán Kiss, György Rokszin, Zsolt Abonyi-Tóth, György Jermendy, Péter Kempler, Dániel Aradi, István Wittmann
Dissimilar impact of type 2 diabetes on cardiovascular outcomes according to age categories: a nationwide population study from Hungary. Cardiovascular diabetology 17 (1) (2018)